DAVID ISAAC
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health YAKIMA, WA NPI 1962089227
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health WA Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$606.31
- Category: General Payments
- Program years: PY2021–2023
- Record count: 23
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $212.86 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $212.86 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $66.67 | 1 |
| Axsome Therapeutics, Inc. | $44.47 | 2 |
| ITI, Inc. | $39.41 | 2 |
| Indivior Inc. | $28.20 | 1 |
| Teva Pharmaceuticals USA, Inc. | $18.69 | 1 |
| Neurocrine BioSciences, Inc. | $15.42 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1034334009 | Indivior Inc. | $28.20 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1040955741 | ITI, Inc. | $22.12 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1040955747 | ITI, Inc. | $17.29 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1052299123 | Neurocrine Biosciences, Inc. | $15.42 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056247529 | Axsome Therapeutics, Inc. | $20.92 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056247531 | Axsome Therapeutics, Inc. | $23.55 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056958427 | Teva Pharmaceuticals USA, Inc. | $18.69 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988277481 | Janssen Pharmaceuticals, Inc | $66.67 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.